Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 37 | $930,954 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
01 Mar 2024 17:46 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 29 Feb 2024 | Sale | 7,169 | 1.58 | 11,327 | D |
01 Mar 2024 17:47 | AKBA | Akebia Therapeutics Inc | BUTLER JOHN P. | CEO and President | 29 Feb 2024 | Sale | 46,570 | 1.58 | 73,581 | D |
01 Mar 2024 17:48 | AKBA | Akebia Therapeutics Inc | HADAS NICOLE R. | SVP, Chief Legal Officer | 29 Feb 2024 | Sale | 5,974 | 1.58 | 9,439 | D |
01 Mar 2024 17:49 | AKBA | Akebia Therapeutics Inc | DAHAN MICHEL | SVP, Chief Operating Officer | 29 Feb 2024 | Sale | 8,661 | 1.58 | 13,684 | D |
29 Feb 2024 18:00 | AKBA | Akebia Therapeutics Inc | BUTLER JOHN P. | CEO and President | 27 Feb 2024 | Sale | 37,733 | 1.52 | 57,354 | D |
29 Feb 2024 18:01 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 27 Feb 2024 | Sale | 8,367 | 1.52 | 12,718 | D |
29 Feb 2024 18:02 | AKBA | Akebia Therapeutics Inc | DAHAN MICHEL | SVP, Chief Operating Officer | 27 Feb 2024 | Sale | 10,744 | 1.52 | 16,331 | D |
29 Feb 2024 18:03 | AKBA | Akebia Therapeutics Inc | HADAS NICOLE R. | SVP, Chief Legal Officer | 27 Feb 2024 | Sale | 7,411 | 1.52 | 11,265 | D |
02 Feb 2024 16:10 | AKBA | Akebia Therapeutics Inc | BUTLER JOHN P. | CEO and President | 01 Feb 2024 | Sale | 46,489 | 1.68 | 78,102 | D |
02 Feb 2024 16:10 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 01 Feb 2024 | Sale | 24,311 | 1.68 | 40,842 | D |
14 May 2024 16:04 | AKBA | Akebia Therapeutics Inc | DAHAN MICHEL | SVP, Chief Operating Officer | 13 May 2024 | Sale | 34,840 | 1.26 | 43,898 | D |
14 May 2024 16:05 | AKBA | Akebia Therapeutics Inc | HADAS NICOLE R. | SVP, Chief Legal Officer | 13 May 2024 | Sale | 12,016 | 1.26 | 15,140 | D |
09 May 2024 17:27 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 25 Aug 2023 | Sale | 27,000 | 1.15 | 31,050 | D |
25 May 2023 21:01 | AKBA | Akebia Therapeutics Inc | DAHAN MICHEL | SVP, Chief Operating Officer | 25 May 2023 | Sale | 95,478 | 1.2229 | 116,760 | D |
25 May 2023 21:01 | AKBA | Akebia Therapeutics Inc | HADAS NICOLE R. | SVP, Chief Legal Officer | 25 May 2023 | Sale | 63,186 | 1.2229 | 77,270 | D |
18 May 2023 18:19 | AKBA | Akebia Therapeutics Inc | SPELLMAN DAVID A | SVP, CFO and Treasurer | 16 May 2023 | Sale | 63,567 | 1.068 | 67,890 | D |
18 May 2023 18:20 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 16 May 2023 | Sale | 63,567 | 1.068 | 67,890 | D |
03 Mar 2023 08:00 | AKBA | Akebia Therapeutics Inc | SPELLMAN DAVID A | SVP, CFO and Treasurer | 01 Mar 2023 | Sale | 810 | 0.8775 | 711 | D |
03 Mar 2023 08:00 | AKBA | Akebia Therapeutics Inc | SPELLMAN DAVID A | SVP, CFO and Treasurer | 01 Mar 2023 | Sale | 6,400 | 0.8775 | 5,616 | D |
03 Mar 2023 08:01 | AKBA | Akebia Therapeutics Inc | DAHAN MICHEL | SVP, Chief Operating Officer | 01 Mar 2023 | Sale | 1,878 | 0.8775 | 1,648 | D |
03 Mar 2023 08:01 | AKBA | Akebia Therapeutics Inc | DAHAN MICHEL | SVP, Chief Operating Officer | 01 Mar 2023 | Sale | 10,476 | 0.8775 | 9,193 | D |
03 Mar 2023 08:01 | AKBA | Akebia Therapeutics Inc | DAHAN MICHEL | SVP, Chief Operating Officer | 01 Mar 2023 | Sale | 8,058 | 0.8775 | 7,071 | D |
03 Mar 2023 08:01 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 01 Mar 2023 | Sale | 1,110 | 0.8775 | 974 | D |
03 Mar 2023 08:01 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 01 Mar 2023 | Sale | 6,400 | 0.8775 | 5,616 | D |
03 Mar 2023 08:01 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 01 Mar 2023 | Sale | 6,613 | 0.8775 | 5,803 | D |
03 Mar 2023 08:01 | AKBA | Akebia Therapeutics Inc | HADAS NICOLE R. | SVP, Chief Legal Officer | 01 Mar 2023 | Sale | 1,088 | 0.8775 | 955 | D |
03 Mar 2023 08:01 | AKBA | Akebia Therapeutics Inc | HADAS NICOLE R. | SVP, Chief Legal Officer | 01 Mar 2023 | Sale | 6,613 | 0.8775 | 5,803 | D |
03 Mar 2023 08:01 | AKBA | Akebia Therapeutics Inc | HADAS NICOLE R. | SVP, Chief Legal Officer | 01 Mar 2023 | Sale | 5,333 | 0.8775 | 4,680 | D |
03 Mar 2023 08:01 | AKBA | Akebia Therapeutics Inc | BUTLER JOHN P. | CEO and President | 01 Mar 2023 | Sale | 6,370 | 0.8775 | 5,590 | D |
03 Mar 2023 08:01 | AKBA | Akebia Therapeutics Inc | BUTLER JOHN P. | CEO and President | 01 Mar 2023 | Sale | 47,239 | 0.8775 | 41,452 | D |
03 Mar 2023 08:01 | AKBA | Akebia Therapeutics Inc | BUTLER JOHN P. | CEO and President | 01 Mar 2023 | Sale | 38,259 | 0.8775 | 33,572 | D |
01 Mar 2023 16:05 | AKBA | Akebia Therapeutics Inc | HADAS NICOLE R. | SVP, Chief Legal Officer | 27 Feb 2023 | Sale | 6,677 | 0.8132 | 5,430 | D |
01 Mar 2023 16:05 | AKBA | Akebia Therapeutics Inc | SPELLMAN DAVID A | SVP, CFO and Treasurer | 27 Feb 2023 | Sale | 7,539 | 0.8132 | 6,131 | D |
01 Mar 2023 16:06 | AKBA | Akebia Therapeutics Inc | DAHAN MICHEL | SVP, Chief Operating Officer | 27 Feb 2023 | Sale | 10,090 | 0.8132 | 8,205 | D |
01 Mar 2023 16:06 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 27 Feb 2023 | Sale | 7,539 | 0.8132 | 6,131 | D |
01 Mar 2023 16:07 | AKBA | Akebia Therapeutics Inc | BUTLER JOHN P. | CEO and President | 27 Feb 2023 | Sale | 38,632 | 0.8132 | 31,416 | D |
01 Sep 2022 16:15 | AKBA | Akebia Therapeutics Inc | BURKE STEVEN KEITH | SVP, Chief Medical Officer | 31 Aug 2022 | Sale | 1,147 | 0.3625 | 416 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)